Zobrazeno 1 - 10
of 37
pro vyhledávání: '"T T, Guyene"'
Autor:
Pierre Corvol, T. T. Guyene, Morris Schambelan, Jean-Paul Saint-André, F. Galland, T. Denolle, Vincent Rohmer, J. C. Bigorgne
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 70:288-292
We recently reported that renin, angiotensinogen, and angiotensin-converting enzyme were present in normal human pituitary lactotroph cells and PRL-secreting adenomas. Angiotensin-II and -III have also been shown to modulate PRL release in vitro. The
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(11)
The T235 allele of the angiotensinogen (AGT) gene is associated with plasma AGT concentration and pregnancy-induced hypertension. The aim of this study was to compare changes in the circulating renin-angiotensin system after short-term (2 days) and r
Publikováno v:
Basic research in cardiology. 94(2)
This study was designed to assess the influence of the activation status of the renin angiotensin system (RAS) on the hemodynamic effects of EXP 3174 (an angiotensin AT1 receptor antagonist) and enalaprilat (an angiotensin converting enzyme inhibitor
Publikováno v:
Presse medicale (Paris, France : 1983). 24(27)
To evaluate diagnostic criteria in primary aldosteronism, we studied the sensitivity and specificity of potassium, renin, aldosterone and the renin/aldosterone ratio in 60 patients undergoing surgery for Conn's adenoma, 50 patients with primary hyper
Autor:
X, Jeunemaitre, A, Charru, L, Pascoe, T T, Guyene, B, Aupetit-Faisant, C H, Shackleton, M, Schambelan, P F, Plouin, P, Corvol
Publikováno v:
Presse medicale (Paris, France : 1983). 24(27)
Dexamethasone-sensitive hyperaldosteronism is associated with early onset hypertension and primary hyperaldosteronism. Diagnosis is difficult but can be improved by genetic testing for the mutant gene.We collected the clinical, biological and genetic
Publikováno v:
Arzneimittel-Forschung. 43(2A)
The blood pressure and renin-angiotensin system effects of the new renin inhibitor, SR 43845 ([N-(pyridyl-3-propionyl)-phenylalanyl- histidyl-(3S,4S) ACHPA-isoleucylamino]-2-methyl-2-dihydroxy-1,3-propane), were studied in 12 hypertensive patients on
Publikováno v:
British journal of clinical pharmacology. 29(5)
1. Cadralazine is a new antihypertensive agent which causes peripheral vasodilation, probably mediated by a hydrazinopyridazine metabolite. 2. The possible influence of acetylator status on the pharmacokinetics and haemodynamics of the drug was studi
Publikováno v:
Journal of Hypertension. 10:1299
Publikováno v:
Advances in prostaglandin and thromboxane research. 7
The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure
Publikováno v:
Circulation. 76(4)
The long-term effect of percutaneous and oral estrogen replacement therapy on blood pressure, plasma renin substrate, and serum estrogens was examined in a 2 year placebo-controlled study with 110 early postmenopausal women. The women were allocated